Review: Hepatocellular carcinoma: the place of new medical therapies
Medical therapies have entered center stage in the treatment of hepatocellular carcinoma (HCC) little more than a year after the positive results of a large phase III trial of sorafenib showed a clear survival benefit with sorafenib, a targeted agent, in this setting.Even though this marks a breakthrough in the treatment of HCC, the narrow patient